Article
Mortality rates of patients treated with drotrecogin alfa for severe sepsis based on PROWESS eligibility
Pharmaceutical Sciences
Document Type
Abstract
Date of Publication
1-1-2007
Event
American College of Clinical Pharmacy Annual Meeting
Disciplines
Citation Information
E. Dodds Ashley, Richard H. Drew, M. Goodwin, D. B. May, et al.. "Mortality rates of patients treated with drotrecogin alfa for severe sepsis based on PROWESS eligibility" (2007) Available at: http://works.bepress.com/richard-drew/112/